FilingSEC EDGAR8-K
Quince Therapeutics Approves Equity Incentive Plan and Increases Authorized Shares
· SEC accepted
StageApproval
Filing content
Quince Therapeutics held a special meeting to approve its 2026 Equity Incentive Plan and increase authorized common stock to 275 million shares.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…